The Anticancer Activity of Indazole Compounds: A Mini Review
Congshan Shang1, Yani Hou1, Tingting Meng1
1Medical College, Xi'an Peihua University, Xi'an 710025, Shaanxi, China.
Current Topics in Medicinal Chemistry
|November 26, 2020
Summary
Indazole compounds show promise as anticancer agents due to their ability to overcome therapy resistance and relapse. This review explores their structural modifications, activity, and mechanisms for developing new cancer treatments.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Oncology
Background:
- Cancer incidence and mortality are rising, with current treatments often failing due to resistance and relapse.
- Heterocyclic compounds are crucial in pharmacology, with the indazole moiety being a key structure.
- Existing indazole-based drugs (e.g., axitinib, pazopanib) show therapeutic value in cancer treatment.
Purpose of the Study:
- To review the anticancer properties of indazole compounds.
- To highlight structural modifications and structure-activity relationships.
- To explore the mechanisms of action for novel anticancer agent development.
Main Methods:
- Literature review of indazole compounds in medicinal chemistry.
- Analysis of structure-activity relationships (SAR) for anticancer properties.
- Examination of documented mechanisms of action for indazole derivatives.
Main Results:
- Indazole compounds demonstrate significant potential as anticancer agents.
- Structural modifications can enhance the efficacy and overcome resistance.
- Several indazole derivatives are effective against various cancer types.
Conclusions:
- Indazole scaffolds are valuable templates for developing novel anticancer therapies.
- Further research into indazole compounds can lead to improved cancer treatment strategies.
- Understanding SAR and mechanisms is key to optimizing indazole-based drug design.
Keywords:
AnticancerDrug-resistantIndazoleLonidamineMechanisms of actionStructure-activity relationshipMore Related Videos
06:34Synthesis of Antiviral Tetrahydrocarbazole Derivatives by Photochemical and Acid-catalyzed C-H Functionalization via Intermediate Peroxides CHIPS
Published on: June 20, 2014
14.1K
09:20Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
Published on: June 26, 2018
8.7K
Related Concept Videos
02:34Inhibition of Cdk Activity
5.4K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.4K
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
662
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
662
02:59Cancer Prevention
7.3K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
7.3K
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
472
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
472
02:57Targeted Cancer Therapies
8.2K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.2K
01:15Drugs that Stabilize Microtubules
2.4K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.4K